Form4insider filings, from the source

SEC Form 4 · accession 0001104659-26-070525

Keenova Therapeutics plc

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Paul Efron
Director
Period of report
Jun 2, 2026
Accepted (ET)
Jun 4, 2026 · 4:12 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001567892

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF1Jun 2, 2026M3,580—A12,045D
Ordinary SharesF2Jun 2, 2026F825—D11,220D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF5,F3,F4—Jun 2, 2026D2,930D——Ordinary Shares2,9307,564D
Restricted Stock UnitsF1,F4—Jun 2, 2026M3,580D——Ordinary Shares3,5803,984D

Explanation of responses

Remarks

This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014.